Cancer

Government agrees to subsidise cancer drug Opdivo

Thousands of Australians fighting late-stage renal and lung cancer will soon get easier access to a new drug.

From Tuesday, the federal government will subsidise Opdivo so that patients will pay just $38.80 per treatment, or $6.30 for those with a concession card.

Opdivo is one of the biggest listings ever on the Pharmaceutical Benefits Scheme
SHARE Share on Facebook SHARE Share on Twitter TWEET Link Opdivo is one of the biggest listings ever on the Pharmaceutical Benefits Scheme Photo: AP

Up to now, patients have had to fork out about $5000 a course – adding up to more than $130,000 per year.

“This drug changes lives and save lives,” Health Minister Greg Hunt said on Sunday.

The drug has been credited with saving the life of AFL star Jarryd Roughead, among others
SHARE Share on Facebook SHARE Share on Twitter TWEET Link The drug has been credited with saving the…